Essential Thrombocythaemia Myelofibrosis
1 clinical trials · Condition
◉ Watch Essential Thrombocythaemia Myelofibrosis
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases (NCT00910728) | AstraZeneca | 2009-05-01 |
Track Essential Thrombocythaemia Myelofibrosis automatically
Every clearance here is in the API, with alerts when new ones post.